First Light Asset Management »

Exelixis shares owned by First Light Asset Management

Quarter-by-quarter ownership of Exelixis (EXEL) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Exelixis

Tip: Access up to 7 years of quarterly data

All positions including Exelixis held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exelixis by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $443k 18k 23.99
2023-09-30 $403k 18k 21.85
2023-06-30 $353k 18k 19.11
2023-03-31 $358k 18k 19.41
2022-12-31 $296k 18k 16.04

More positions owned by First Light Asset Management

Karuna Therapeutics Common Stocks
Alphatec Holdings Common Stocks (ATEC)
Xenon Pharmaceuticals Common Stocks (XENE)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Pliant Therapeutics Common Stocks (PLRX)
Neogenomics Common Stocks (NEO)
Transmedics Group Common Stocks (TMDX)
Si-bone Common Stocks (SIBN)
Atricure Common Stocks (ATRC)
Paragon 28 Common Stocks (FNA)
Model N Common Stocks (MODN)
Tactile Systems Technology Common Stocks (TCMD)
Prothena Corporation Common Stocks (PRTA)
Ultragenyx Pharmaceutical Common Stocks (RARE)
Performant Financial Corporation Common Stocks (PFMT)

View all positions for First Light Asset Management

Top funds holding Exelixis

Vanguard Group
Jpmorgan Chase & Co
Dimensional Fund Advisors
T. Rowe Price Associates
Charles Schwab Investment Management
Norges Bank Investment Management
Bank of New York Mellon
Point72 Asset Management
Thomas Stevens, CFA"
Jacobs Levy Equity Management
Meditor
AQR Capital Management
Bellevue Group
Bank of America Corporation
CalPERS

View all funds holding Exelixis